How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment?

How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment?

How do you select patients with solid tumors that are appropriate for NGS? Is it useful just for patients with cancer at time of presentation? Can it be used for patients under treatment? For assessment of tumors in patients who have relapsed?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Nong Xu, MD

Professor Nong Xu, MD

Department of Medical Oncology
The First Affiliated Hospital, School of Medicine
Zhejiang University
Hangzhou, China